The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Panitumumab plus trifluridine/tipiracil as third-line anti-EGFR rechallenge therapy in chemo-refractory RAS WT metastatic colorectal cancer: The VELO randomized phase II clinical trial.
 
Stefania Napolitano
Speakers' Bureau - Novartis
 
Vincenzo De Falco
No Relationships to Disclose
 
Giulia Martini
No Relationships to Disclose
 
Lucia Esposito
No Relationships to Disclose
 
Vincenzo Famiglietti
No Relationships to Disclose
 
Erika Martinelli
Consulting or Advisory Role - AstraZeneca; Roche
Speakers' Bureau - Amgen; Merck Serono; Pierre Fabre; SERVIER
 
Davide Ciardiello
No Relationships to Disclose
 
Francesca Marrone
No Relationships to Disclose
 
Antonio Avallone
Speakers' Bureau - Amgen; SERVIER
 
Claudia Cardone
No Relationships to Disclose
 
Alfonso De Stefano
No Relationships to Disclose
 
Vincenzo Montesarchio
No Relationships to Disclose
 
M. Giulia Zampino
No Relationships to Disclose
 
Roberto Bordonaro
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi
 
Mario Scartozzi
Speakers' Bureau - Amgen; Lilly; MSD
 
Daniele Santini
No Relationships to Disclose
 
Massimo Di Maio
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Eisai; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Eisai; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Research Funding - GlaxoSmithKline (Inst); Tesaro (Inst)
 
Fortunato Ciardiello
Consulting or Advisory Role - Amgen; Bayer; Merck KGaA; Pfizer; Roche/Genentech
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Roche/Genentech (Inst); SERVIER (Inst); Symphogen (Inst)
 
Teresa Troiani
Consulting or Advisory Role - BMS Italy; Novartis; Pfizer; SERVIER